Aspartate α-decarboxylase a new therapeutic target in the fight against Helicobacter pylori infection

Effective eradication therapy for Helicobacter pylori is a worldwide demand. Aspartate α-decarboxylase (ADC) was reported as a drug target in H. pylori, in an in silico study, with malonic acid (MA) as its inhibitor. We evaluated eradicating H. pylori infection through ADC inhibition and the possibi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ibrahim, Kareem A., Kashef, Mona T., Elkhamissy, Tharwat R., Ramadan, Mohammed A., Helmy, Omneya M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746714/
https://www.ncbi.nlm.nih.gov/pubmed/36523828
http://dx.doi.org/10.3389/fmicb.2022.1019666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746714/
https://www.ncbi.nlm.nih.gov/pubmed/36523828
http://dx.doi.org/10.3389/fmicb.2022.1019666

Ejemplares similares